- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.26 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 6 residues within 4Å:- Chain A: T.189, T.190, L.227, N.230, E.231, Y.234
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.230
NAG.3: 1 residues within 4Å:- Chain A: N.211
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.211
NAG.4: 2 residues within 4Å:- Chain A: N.201, E.202
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:E.202
NAG.5: 3 residues within 4Å:- Chain A: K.238, R.239, N.241
No protein-ligand interaction detected (PLIP)NAG.18: 6 residues within 4Å:- Chain C: T.189, T.190, L.227, N.230, E.231, Y.234
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.230
NAG.19: 1 residues within 4Å:- Chain C: N.211
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.211
NAG.20: 2 residues within 4Å:- Chain C: N.201, E.202
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.202
NAG.21: 3 residues within 4Å:- Chain C: K.238, R.239, N.241
No protein-ligand interaction detected (PLIP)NAG.34: 6 residues within 4Å:- Chain E: T.189, T.190, L.227, N.230, E.231, Y.234
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.230
NAG.35: 1 residues within 4Å:- Chain E: N.211
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.211
NAG.36: 2 residues within 4Å:- Chain E: N.201, E.202
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:E.202
NAG.37: 3 residues within 4Å:- Chain E: K.238, R.239, N.241
No protein-ligand interaction detected (PLIP)- 18 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 5 residues within 4Å:- Chain A: W.77, A.78, E.79, F.263
- Chain B: H.15
Ligand excluded by PLIPGOL.7: 7 residues within 4Å:- Chain A: E.93, C.94, L.95, P.96, D.123, F.124, R.145
Ligand excluded by PLIPGOL.8: 8 residues within 4Å:- Chain A: V.10, I.11, D.28, K.29, Q.35, L.159, P.160, Q.161
Ligand excluded by PLIPGOL.9: 9 residues within 4Å:- Chain A: N.42, L.43, E.44, T.50, R.58, N.80, Y.82, A.150, E.151
Ligand excluded by PLIPGOL.13: 6 residues within 4Å:- Chain B: N.62, E.63, T.65, Q.66
- Chain F: W.30
- Ligands: NAG-NAG.1
Ligand excluded by PLIPGOL.14: 9 residues within 4Å:- Chain A: S.5, D.20, V.21, D.22
- Chain B: K.87, D.90
- Chain E: S.32, N.34
- Ligands: DMS.11
Ligand excluded by PLIPGOL.22: 5 residues within 4Å:- Chain C: W.77, A.78, E.79, F.263
- Chain D: H.15
Ligand excluded by PLIPGOL.23: 7 residues within 4Å:- Chain C: E.93, C.94, L.95, P.96, D.123, F.124, R.145
Ligand excluded by PLIPGOL.24: 8 residues within 4Å:- Chain C: V.10, I.11, D.28, K.29, Q.35, L.159, P.160, Q.161
Ligand excluded by PLIPGOL.25: 9 residues within 4Å:- Chain C: N.42, L.43, E.44, T.50, R.58, N.80, Y.82, A.150, E.151
Ligand excluded by PLIPGOL.29: 6 residues within 4Å:- Chain B: W.30
- Chain D: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG.17
Ligand excluded by PLIPGOL.30: 9 residues within 4Å:- Chain A: S.32, N.34
- Chain C: S.5, D.20, V.21, D.22
- Chain D: K.87, D.90
- Ligands: DMS.27
Ligand excluded by PLIPGOL.38: 5 residues within 4Å:- Chain E: W.77, A.78, E.79, F.263
- Chain F: H.15
Ligand excluded by PLIPGOL.39: 7 residues within 4Å:- Chain E: E.93, C.94, L.95, P.96, D.123, F.124, R.145
Ligand excluded by PLIPGOL.40: 8 residues within 4Å:- Chain E: V.10, I.11, D.28, K.29, Q.35, L.159, P.160, Q.161
Ligand excluded by PLIPGOL.41: 9 residues within 4Å:- Chain E: N.42, L.43, E.44, T.50, R.58, N.80, Y.82, A.150, E.151
Ligand excluded by PLIPGOL.45: 6 residues within 4Å:- Chain D: W.30
- Chain F: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG.33
Ligand excluded by PLIPGOL.46: 9 residues within 4Å:- Chain C: S.32, N.34
- Chain E: S.5, D.20, V.21, D.22
- Chain F: K.87, D.90
- Ligands: DMS.43
Ligand excluded by PLIP- 6 x IXX: 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE(Non-covalent)
IXX.10: 9 residues within 4Å:- Chain A: I.11, L.16, V.39, L.157, I.158, L.159
- Chain B: L.14, M.47
- Ligands: IXX.15
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:I.11, A:I.11, A:L.16, A:V.39, A:L.157, A:L.157, B:L.14
IXX.15: 6 residues within 4Å:- Chain A: R.37, A.74
- Chain B: Y.16, Q.20, I.43
- Ligands: IXX.10
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:Y.16, A:A.74
- Hydrogen bonds: B:Q.20
IXX.26: 9 residues within 4Å:- Chain C: I.11, L.16, V.39, L.157, I.158, L.159
- Chain D: L.14, M.47
- Ligands: IXX.31
7 PLIP interactions:6 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:I.11, C:I.11, C:L.16, C:V.39, C:L.157, C:L.157, D:L.14
IXX.31: 6 residues within 4Å:- Chain C: R.37, A.74
- Chain D: Y.16, Q.20, I.43
- Ligands: IXX.26
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:A.74, D:Y.16
- Hydrogen bonds: D:Q.20
IXX.42: 9 residues within 4Å:- Chain E: I.11, L.16, V.39, L.157, I.158, L.159
- Chain F: L.14, M.47
- Ligands: IXX.47
7 PLIP interactions:6 interactions with chain E, 1 interactions with chain F- Hydrophobic interactions: E:I.11, E:I.11, E:L.16, E:V.39, E:L.157, E:L.157, F:L.14
IXX.47: 6 residues within 4Å:- Chain E: R.37, A.74
- Chain F: Y.16, Q.20, I.43
- Ligands: IXX.42
3 PLIP interactions:2 interactions with chain F, 1 interactions with chain E- Hydrophobic interactions: F:Y.16, E:A.74
- Hydrogen bonds: F:Q.20
- 9 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.11: 7 residues within 4Å:- Chain A: R.4, S.5, I.6
- Chain B: F.71, R.86, K.87
- Ligands: GOL.14
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:K.87, A:I.6
DMS.12: 3 residues within 4Å:- Chain A: Y.186, Y.187, S.188
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.188
DMS.16: 6 residues within 4Å:- Chain A: V.18
- Chain B: E.1, A.2, I.3, V.4, E.63
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:V.4
- Salt bridges: B:E.1, B:E.63
DMS.27: 7 residues within 4Å:- Chain C: R.4, S.5, I.6
- Chain D: F.71, R.86, K.87
- Ligands: GOL.30
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain C- Hydrogen bonds: D:K.87, C:I.6
DMS.28: 3 residues within 4Å:- Chain C: Y.186, Y.187, S.188
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.188
DMS.32: 6 residues within 4Å:- Chain C: V.18
- Chain D: E.1, A.2, I.3, V.4, E.63
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:V.4
- Salt bridges: D:E.1, D:E.63
DMS.43: 7 residues within 4Å:- Chain E: R.4, S.5, I.6
- Chain F: F.71, R.86, K.87
- Ligands: GOL.46
2 PLIP interactions:1 interactions with chain F, 1 interactions with chain E- Hydrogen bonds: F:K.87, E:I.6
DMS.44: 3 residues within 4Å:- Chain E: Y.186, Y.187, S.188
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:S.188
DMS.48: 6 residues within 4Å:- Chain E: V.18
- Chain F: E.1, A.2, I.3, V.4, E.63
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:V.4
- Salt bridges: F:E.1, F:E.63
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Structures of Ebola Virus Glycoprotein Complexes with Tricyclic Antidepressant and Antipsychotic Drugs. J. Med. Chem. (2018)
- Release Date
- 2018-05-23
- Peptides
- Envelope glycoprotein,Envelope glycoprotein: ACE
Envelope glycoprotein: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.26 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x GOL: GLYCEROL(Non-functional Binders)
- 6 x IXX: 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE(Non-covalent)
- 9 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Structures of Ebola Virus Glycoprotein Complexes with Tricyclic Antidepressant and Antipsychotic Drugs. J. Med. Chem. (2018)
- Release Date
- 2018-05-23
- Peptides
- Envelope glycoprotein,Envelope glycoprotein: ACE
Envelope glycoprotein: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B